NIH Intramural ME/CFS Study

You are here

NIH Intramural ME/CFS Study

Overview

In 2016, the 2023 ��ѿ��ý (NIH) launched the , which took place at the NIH Clinical Center in Bethesda, MD. The study focused on individuals who developed myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) after an infection and had been diagnosed within the previous 5 years. The goal was to closely examine the clinical and biological characteristics of the disease to improve our understanding of its causes and progression. The collaborative study was led by , clinical director at the National Institute of Neurological Disorders and Stroke (NINDS) and involved researchers from other Institutes and Centers at the NIH, and from outside research institutions.

Publications

Walitt B, et al. Nat Commun. 2024 Feb 21;15(1):907. doi: 10.1038/s41467-024-45107-3. PMID: 38383456; PMCID: PMC10881493.

NIH Intramural ME/CFS Study Q&A

Stussman B, Calco B, Norato G, Gavin A, Chigurupati S, Nath A, Walitt B. BMJ Neurol Open. 2024 Feb 10;6(1):e000529. doi: 10.1136/bmjno-2023-000529. PMID: 38352048; PMCID: PMC10862339.

Stussman B, Williams A, Snow J, Gavin A, Scott R, Nath A, Walitt B. Front Neurol. 2020 Sep 18;11:1025. doi: 10.3389/fneur.2020.01025. PMID: 33071931; PMCID: PMC7530890.